Workers on daily probiotics less likely to take time off sick

Workers who take probiotics daily are less likely to be off work with common illnesses, such as colds and gastroenteritis, than workers who don’t. An exploratory study published today in the open access journal Environmental Health shows that workers who took a daily dose of the probiotic bacteria Lactobacillus reuteri were 2.5 times less likely to take sick leave than workers who took a placebo.


Py Tubelius, from Tetra Pak Occupational Health and Safety AB, and colleagues from BioGaia AB, in Lund, Sweden, conducted a study to assess the health benefits for adults of taking L. reuteri on a daily basis. A group of 181 staff (128 day workers and 53 shift workers) at the Tetra Pak factory in Lund agreed to take part in the study. The workers were randomly assigned at the start of the study, to receive a drink with or without L. reuteri, every day for a period of 80 days.

Twenty-three of the 87 workers in the group that took a placebo reported taking sick days during the 80 day-long study. In contrast, only 10 of the 94 workers that took L. reuteri reported taking any sick days during the study. The effect of L. reuteri was most significant in shift workers: none of the 26 shift workers in the reuteri group reported taking any sick leave, compared to nine out of 27 shift workers in the placebo group.

Media Contact

Juliette Savin EurekAlert!

More Information:

http://www.biomedcentral.com

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Economies take off with new airports

A global study by an SUTD researcher in collaboration with scientists from Japan explores the economic benefits of airport investment in emerging economies using nighttime satellite imagery. Be it for…

CAR T–cell immunotherapy targets

Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets. Scientists at St. Jude Children’s Research Hospital found 156 potential CAR targets across the brain and solid tumors,…

Stony coral tissue loss disease

… is shifting the ecological balance of Caribbean reefs. The outbreak of a deadly disease called stony coral tissue loss disease is destroying susceptible species of coral in the Caribbean…

Partners & Sponsors